clinical trials – SRK Analytics

Eli Lilly Targets 2027 Approval for Next-Generation Triple-Agonist Obesity Drug Retatrutide

Eli Lilly plans to seek approval for its next-generation obesity drug retatrutide by 2027 following highly successful late-stage clinical trials.

Prasenjit Bhowmik July 24, 2026

Business Insights

Suven’s High-Stakes Neuroscience Bet Enters Decisive Late-Stage Clinical Trials

Suven Life Sciences, a leading Indian biopharmaceutical innovator, has entered the final stretch of clinical development for its ambitious central nervous system (CNS) pipeline, positioning itself to address some of…

Prasenjit Bhowmik July 20, 2026

Emerging Market

UniQure to Seek FDA Approval for Huntington’s Disease Gene Therapy Following Regulatory Dispute

UniQure is pursuing FDA approval for its Huntington's disease gene therapy AMT-130, navigating past regulatory hurdles for this promising treatment.

Prasenjit Bhowmik June 28, 2026